Neoleukin Therapeutics (NLTX) Q4 2023 Earnings

18MarExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.41
-0.29
-0.16
-0.04

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Neoleukin Therapeutics (NLTX) will report earnings of for Q4 2023 on March 18, 2024.

0 Comments

Share your thoughts